Literature DB >> 3957739

Radiotherapeutic prophylaxis of estrogen-induced gynecomastia: a study of late sequela.

D Fass, A Steinfeld, J Brown, A Tessler.   

Abstract

Radiation therapy is an effective means of preventing the development of hormone-induced gynecomastia in men with cancer of the prostate. The efficacy and morbidity of this type of radiation was studied in a retrospective analysis of 87 patients referred for treatment from 1972 to 1982. Patients receiving DES as treatment for prostate carcinoma were treated with irradiation to the breast tissue. Patients were treated with 4 MV, 60Co superficial X rays. Doses range from 1200 to 1500 cGy in 3 fractions. The majority of patients had satisfactory results in terms of prevention of gynecomastia and mammalgia. There were few acute reactions noted and no evidence of long term sequela.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3957739     DOI: 10.1016/0360-3016(86)90359-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

Review 1.  Mesenchymal stem cells and the embryonic reawakening theory of BPH.

Authors:  W Nathaniel Brennen; John T Isaacs
Journal:  Nat Rev Urol       Date:  2018-11       Impact factor: 14.432

Review 2.  Radiation therapy for the treatment of benign vascular, skeletal and soft tissue diseases.

Authors:  A Montero Luis; R Hernanz de Lucas; A Hervás Morón; E Fernández Lizarbe; S Sancho García; C Vallejo Ocaña; A Polo Rubio; A Ramos Aguerri
Journal:  Clin Transl Oncol       Date:  2008-06       Impact factor: 3.405

3.  Radiotherapy for prevention and therapy of gynecomastia due to antiandrogen treatment in prostate cancer patients: a patterns-of-care study.

Authors:  Burkhard Neu; Verena Sautter; Felix Momm; Ute Melcher; Heinrich Seegenschmiedt; Oliver Micke; Marie-Luise Sautter-Bihl
Journal:  Strahlenther Onkol       Date:  2011-11-29       Impact factor: 3.621

Review 4.  Prostate stem cells and benign prostatic hyperplasia.

Authors:  John T Isaacs
Journal:  Prostate       Date:  2008-06-15       Impact factor: 4.104

5.  Management options for gynaecomastia and breast pain associated with nonsteroidal antiandrogen therapy : case report series.

Authors:  I Leibovitch; D Gillatt; P Hopwood; P Iversen; R E Mansel; D McLeod; R Vela-Navarrete; P Richaud; W See; C Tyrrell; M Wirth
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 6.  Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review.

Authors:  Frank Kunath; Bastian Keck; Gerd Antes; Bernd Wullich; Joerg J Meerpohl
Journal:  BMC Med       Date:  2012-08-28       Impact factor: 8.775

7.  Androgen deprivation therapy toxicity and management for men receiving radiation therapy.

Authors:  Matthew E Johnson; Mark K Buyyounouski
Journal:  Prostate Cancer       Date:  2012-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.